Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3761926011 | Mirtazapine 15 mg orodispersible tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3761927019 | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
56946901000001114 | Mirtazapine 15mg orodispersible tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing mirtazapine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Oral form mirtazapine disintegrating tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has active ingredient | Mirtazapine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 15 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only mirtazapine in oromucosal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance | Mirtazapine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Mirtazapine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Plays role | Antidepressant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only mirtazapine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tabletdispersible.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Mirtazapine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release oral lyophilisate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release oral lyophilisate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has specific active ingredient | Mirtazapine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has dispensed dose form | Orodispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has dispensed dose form | Conventional release orodispersible tablet | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Zispin SolTab 15mg orodispersible tablets (Organon Pharma (UK) Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets 30 tablet | Is pack of | False | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets 6 tablet | Is pack of | False | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (PI) (Waymade Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Imported) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Medihealth (Northern) Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Teva UK Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Actavis UK Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (UniChem Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Genus Pharmaceuticals Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (Dowelhurst Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Consilient Health Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets 6 tablet | Has VMP | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets 30 tablet | Has VMP | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (Lexon (UK) Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Pfizer Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Almus Pharmaceuticals Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Zispin SolTab 15mg orodispersible tablets (Necessity Supplies Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Milpharm Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Bluefish Pharmaceuticals AB) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Waymade Healthcare Plc) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Wockhardt UK Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (DE Pharmaceuticals) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Mirtazapine 15mg orodispersible tablets (Medreich Plc) | Is a | True | Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets